Historical salary details - Dr. Jonathan C. Javitt,M.D.,M.P.H., Chairman of the Board, Chief Scientist and Interim Chief Executive Officer, NRX Pharmaceuticals Inc
Dr. Jonathan C. Javitt,M.D.,M.P.H. has been the Chairman of the Board, Chief Scientist and Interim Chief Executive Officer of NRX Pharmaceuticals Inc since 08 Jul 2021 and his latest salary was 825 K. View his historical salary.
Dr. Jonathan C. Javitt,M.D.,M.P.H.
Chairman of the Board, Chief Scientist and Interim Chief Executive Officer
$ 825 K
Gross Remuneration
-
Current Company
NRX Pharmaceuticals Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | NRX Pharmaceuticals Inc | Chairman of the Board, Chief Scientist and Interim Chief Executive Officer | 825 K | 30.9 % |
| 2023 | NRX Pharmaceuticals Inc | Chairman of the Board and Chief Scientist | 630.2 K | -27.9 % |
| 2022 | NRX Pharmaceuticals Inc | Director and Chief Scientist | 873.7 K | 131.6 % |
| 2021 | NRX Pharmaceuticals Inc | - | 377.3 K | - |
| 2021 | NRX Pharmaceuticals Inc | Chairman of the Board and Chief Scientist | 377.3 K | - |
| 2020 | NRX Pharmaceuticals Inc | - | 614.6 K | - |
| 2020 | NRX Pharmaceuticals Inc | - | 614.6 K | - |
| 2020 | NRX Pharmaceuticals Inc | Chairman of the Board and Chief Executive Officer | - | - |